Principal Investigator
Henry Moore
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220437
Clinical Trial Summary
A 28-Day Randomized, Placebo-Controlled, Double-Blind,Parallel Groups and Normative Comparison Study toEvaluate the Effect of SAGE-718 on Functioning Capacity inParticipants with Huntingtons Disease
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Movement Disorders
Contact Information
Study Contact
Marta Smolinska Paleta
Phone Number
+1 (561) 9394169
Email
mxp2121@miami.edu